Nastech Pharmaceutical Company Inc. (NSTK) Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer
6/10/2008 2:30:58 PM
More...
|
Nastech Pharmaceutical Company Inc. (NSTK) Announces Positive Intranasal Insulin Data at American Diabetes Association Meeting
6/9/2008 10:31:48 AM
More...
|
Nastech Pharmaceutical Company Inc. (NSTK) Announces First Quarter 2008 Financial Results
5/9/2008 9:04:52 AM
More...
|
Nastech Pharmaceutical Company Inc. (NSTK) to Release First Quarter Financial Results and Host Webcast on Thursday, May 8, 2008
5/2/2008 10:07:12 AM
More...
|
Nastech Pharmaceutical Company Inc. (NSTK) Raises $7.93 Million in Registered Direct Offering
4/25/2008 6:10:23 AM
More...
|
Nastech Pharmaceutical Company Inc. (NSTK) Announces Appointment of Gunter Blobel, M.D., Ph.D., to its MDRNA, Inc. Scientific Advisory Board
3/27/2008 8:44:49 AM
More...
|
Nastech Pharmaceutical Company Inc. (NSTK) to Present RNAi Data
3/25/2008 10:48:58 AM
More...
|
Nastech Pharmaceutical Company Inc. (NSTK) Complies with Nasdaq Marketplace Rule 4350(b)(1)(B)
3/24/2008 10:19:52 AM
More...
|
Wall Street Media Presents a Video of Dr. Gordon Brandt, President of Nastech Pharmaceutical Company Inc. (NSTK)
3/19/2008 9:59:47 AM
More...
|
Nastech Pharmaceutical Company Inc. (NSTK) Announces Fourth Quarter and Full Year 2007 Financial Results
3/18/2008 10:38:42 AM
More...
|
|